vidarabine has been researched along with aphidicolin in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (50.00) | 18.7374 |
| 1990's | 8 (33.33) | 18.2507 |
| 2000's | 2 (8.33) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chubb, S; Huang, P; Plunkett, W | 1 |
| Azzam, EI; Feeley, M; Raaphorst, GP; Sargent, MD | 1 |
| Iliakis, G; Okayasu, R; Pantelias, G; Seaner, R | 1 |
| Dahlberg, WK; Little, JB; Ueno, AM | 1 |
| Kelland, LR; Steel, GG | 1 |
| Leonard, JC; Leonard, RC; Thompson, KH | 1 |
| Iliakis, G; Ngo, FQ | 1 |
| Kufe, DW; Spriggs, DR | 1 |
| Mishra, NC; Vishwanatha, JK | 2 |
| Ayusawa, D; Iwata, K; Seno, T | 1 |
| Bastow, KF; Cheng, YC; Derse, DD | 1 |
| Hodgson, GS; Moore, RC | 1 |
| Ayurawa, D; Iwata, K; Seno, T | 1 |
| Huang, P; Plunkett, W | 1 |
| Brinkman, W; Heaton, D; Mustafi, R; Schwartz, JL | 1 |
| Smit, JA; Stark, JH | 1 |
| Adachi, S; Akiyama, Y; Hirota, H; Kasai, Y; Kubota, M; Kuwakado, K; Matsubara, K; Mikawa, H | 1 |
| Ballal, K; Huang, P; Plunkett, W | 1 |
| Huang, P; Plunkett, W; Robertson, LE; Wright, S | 1 |
| Kawai, Y; Ueda, T; Yamauchi, T | 1 |
| Plunkett, W; Rao, VA | 1 |
| Amsailale, R; Arts, A; Bontemps, F; Smal, C; Starczewska, E; Van Den Neste, E | 1 |
| Arana Echarri, A; Beyaert, M; Bol, V; Bontemps, F; Michaux, L; Saussoy, P; Smal, C; Starczewska, E; Van Den Neste, E; Vekemans, MC | 1 |
1 review(s) available for vidarabine and aphidicolin
| Article | Year |
|---|---|
Biochemical and cellular pharmacology of cytosine arabinoside.
Topics: Animals; Aphidicolin; Arabinofuranosylcytosine Triphosphate; Binding, Competitive; Cell Line; Cell Survival; Centrifugation, Density Gradient; Cytarabine; Diterpenes; DNA; DNA Repair; DNA Replication; Fibroblasts; Granulocytes; Humans; Kinetics; Leukemia L1210; Leukemia, Myeloid, Acute; Nucleic Acid Synthesis Inhibitors; Templates, Genetic; Vidarabine | 1985 |
23 other study(ies) available for vidarabine and aphidicolin
| Article | Year |
|---|---|
Termination of DNA synthesis by 9-beta-D-arabinofuranosyl-2-fluoroadenine. A mechanism for cytotoxicity.
Topics: Aphidicolin; Arabinonucleotides; Cell Line; Cell Survival; Clone Cells; Diterpenes; DNA Replication; DNA-Directed DNA Polymerase; Guanosine Monophosphate; Humans; Kinetics; Nucleic Acid Synthesis Inhibitors; Vidarabine; Vidarabine Phosphate | 1990 |
Inhibitors of repair of potentially lethal damage and DNA polymerases also influence the recovery of potentially neoplastic transforming damage in C3H10T-1/2 cells.
Topics: Animals; Aphidicolin; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Diterpenes; DNA Polymerase I; DNA Polymerase II; DNA Repair; Mice; Mice, Inbred C3H; Vidarabine | 1990 |
Comparative studies on repair inhibition by araA, araC and aphidicolin of radiation induced DNA and chromosome damage in rodent cells: comparison with fixation of PLD.
Topics: Animals; Aphidicolin; Cell Line; Cell Survival; Chromosomes; Cricetinae; Cytarabine; Diterpenes; DNA; DNA Damage; DNA Repair; DNA Replication; Vidarabine | 1989 |
Differential response of human and rodent cell lines to chemical inhibition of the repair of potentially lethal damage.
Topics: Adenosine Diphosphate Ribose; Animals; Aphidicolin; Benzamides; Cell Line; Cricetinae; Cricetulus; Cytarabine; Diterpenes; DNA Polymerase II; DNA Repair; Fibroblasts; Humans; Hydroxyurea; Mice; Vidarabine | 1989 |
Modification of radiation dose-rate sparing effects in a human carcinoma of the cervix cell line by inhibitors of DNA repair.
Topics: Aphidicolin; Benzamides; Caffeine; Cell Line; Cobalt Radioisotopes; Diterpenes; DNA Repair; Female; Humans; Hydroxyurea; In Vitro Techniques; Novobiocin; Radiation Dosage; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Vidarabine | 1988 |
Arabinofuranosyl nucleosides induce common fragile sites.
Topics: Aphidicolin; Chromosome Fragile Sites; Chromosome Fragility; Cytarabine; Diterpenes; Female; Humans; Male; Nucleic Acid Synthesis Inhibitors; Vidarabine | 1988 |
Effects of aphidicolin on the repair and fixation of potentially lethal damage sensitive to beta-araA.
Topics: Animals; Aphidicolin; Cell Line; Cell Survival; Cricetinae; Diterpenes; DNA Polymerase II; DNA Repair; In Vitro Techniques; Vidarabine | 1985 |
Chinese hamster ovary cell mutants resistant to DNA polymerase inhibitors. I. Isolation and biochemical genetic characterization.
Topics: Animals; Aphidicolin; Cell Division; Cell Line; Cricetinae; Cricetulus; Cytarabine; Diterpenes; DNA Polymerase II; Drug Resistance; Female; Kinetics; Mutation; Nucleic Acid Synthesis Inhibitors; Ovary; Vidarabine | 1985 |
Chinese hamster ovary cell mutants resistant to DNA polymerase inhibitors. II. Segregational analysis and DNA transfection of the aphr gene.
Topics: Animals; Aphidicolin; Cell Line; Cricetinae; Cricetulus; Cytarabine; Diterpenes; DNA; DNA Polymerase II; Drug Resistance; Female; Genes; Mutation; Nucleic Acid Synthesis Inhibitors; Ovary; Transfection; Vidarabine | 1985 |
Unusual sensitivity to bleomycin and joint resistance to 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine of mouse FM3A cell mutants with altered ribonucleotide reductase and thymidylate synthase.
Topics: Animals; Antibiotics, Antineoplastic; Aphidicolin; Bleomycin; Cell Line; Cell Survival; Cytarabine; Diterpenes; Drug Resistance; Kinetics; Mammary Neoplasms, Experimental; Methyltransferases; Mice; Mice, Inbred C3H; Mutation; Ribonucleotide Reductases; Thymidylate Synthase; Vidarabine | 1983 |
Susceptibility of phosphonoformic acid-resistant herpes simplex virus variants to arabinosylnucleosides and aphidicolin.
Topics: Antiviral Agents; Aphidicolin; Arabinonucleosides; Coformycin; Diterpenes; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Pentostatin; Phosphonoacetic Acid; Simplexvirus; Thymidine; Thymidine Kinase; Vidarabine | 1983 |
Clastogenic effect of DNA synthesis inhibitors in cells exposed in G2.
Topics: Animals; Aphidicolin; Cell Line; Chromosomes; Diterpenes; DNA; DNA Polymerase II; DNA Replication; Interphase; Marsupialia; Metaphase; Mutation; Nucleic Acid Synthesis Inhibitors; Vidarabine | 1983 |
Increased level of ribonucleotide reductase and associated resistance to aphidicolin in mouse FM3A cell mutants selected for simultaneous resistance to 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine.
Topics: Animals; Aphidicolin; Cells, Cultured; Cytarabine; Diterpenes; DNA Polymerase II; Drug Resistance; Hydroxyurea; Mice; Mutation; Nucleic Acid Synthesis Inhibitors; Phenotype; Ribonucleotide Reductases; Thymidine; Vidarabine | 1982 |
Fludarabine- and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Aphidicolin; Apoptosis; Cell Cycle; Cell Line; Cell Membrane; Deoxycytidine; DNA Replication; DNA, Neoplasm; Gemcitabine; Humans; Kinetics; T-Lymphocytes; Time Factors; Tumor Cells, Cultured; Vidarabine | 1995 |
Enhancement of X-ray toxicity in squamous cell carcinoma cell lines by DNA polymerase inhibitors.
Topics: Aphidicolin; Carcinoma, Squamous Cell; Cell Survival; Cytarabine; DNA Repair; DNA Replication; DNA, Neoplasm; Humans; In Vitro Techniques; Nucleic Acid Synthesis Inhibitors; Tumor Cells, Cultured; Vidarabine; X-Rays | 1994 |
Inhibiting the repair of DNA damage induced by gamma irradiation in rat thymocytes.
Topics: Animals; Antineoplastic Agents; Aphidicolin; Benzamides; Cytarabine; DNA Damage; DNA Repair; Doxorubicin; Flavonoids; Gamma Rays; Kinetics; Naphthoquinones; Novobiocin; Radiation-Sensitizing Agents; Rats; Rats, Sprague-Dawley; T-Lymphocytes; Time Factors; Vidarabine | 1994 |
Aphidicolin potentiates apoptosis induced by arabinosyl nucleosides in human myeloid leukemia cell lines.
Topics: Aphidicolin; Apoptosis; Arabinonucleosides; DNA; Drug Synergism; Electrophoresis, Agar Gel; Humans; Leukemia, Myeloid; Tumor Cells, Cultured; Vidarabine | 1993 |
Biochemical characterization of the protein activity responsible for high molecular weight DNA fragmentation during drug-induced apoptosis.
Topics: Antineoplastic Agents; Aphidicolin; Apoptosis; Cell Fusion; Cell Line; Cysteine Endopeptidases; Deoxycytidine; DNA Fragmentation; DNA, Neoplasm; Electrophoresis, Gel, Pulsed-Field; Gemcitabine; Humans; In Vitro Techniques; Molecular Weight; Nucleosomes; Vidarabine | 1997 |
High molecular weight DNA fragmentation: a critical event in nucleoside analogue-induced apoptosis in leukemia cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aphidicolin; Apoptosis; Chelating Agents; Deoxycytidine; DNA Fragmentation; DNA, Neoplasm; Egtazic Acid; Enzyme Inhibitors; Gemcitabine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Molecular Weight; Tumor Cells, Cultured; Vidarabine | 1995 |
Inhibition of nucleotide excision repair by fludarabine in normal lymphocytes in vitro, measured by the alkaline single cell gel electrophoresis (Comet) assay.
Topics: Antineoplastic Agents; Aphidicolin; Apoptosis; Comet Assay; DNA Repair; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Hydroxyurea; Kinetics; Lymphocytes; Time Factors; Ultraviolet Rays; Vidarabine | 2002 |
Activation of a p53-mediated apoptotic pathway in quiescent lymphocytes after the inhibition of DNA repair by fludarabine.
Topics: Aphidicolin; Apoptosis; Caspase 3; Caspase 8; Caspases; Cell Survival; Cells, Cultured; DNA Repair; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Fas Ligand Protein; fas Receptor; Humans; Immunoblotting; Lymphocytes; Membrane Glycoproteins; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serine; Signal Transduction; Time Factors; Tumor Suppressor Protein p53; Ultraviolet Rays; Vidarabine | 2003 |
Phosphorylation of deoxycytidine kinase on Ser-74: impact on kinetic properties and nucleoside analog activation in cancer cells.
Topics: Antineoplastic Agents; Aphidicolin; Biotransformation; Cell Line, Tumor; Cell Survival; Cladribine; Deoxycytidine; Deoxycytidine Kinase; Enzyme Activation; Gemcitabine; HCT116 Cells; HT29 Cells; Humans; Kinetics; Mutation; Phosphorylation; Purine Nucleosides; Pyrimidine Nucleosides; Serine; Structure-Activity Relationship; Substrate Specificity; Vidarabine | 2012 |
Targeting DNA repair with aphidicolin sensitizes primary chronic lymphocytic leukemia cells to purine analogs.
Topics: Antineoplastic Agents; Aphidicolin; Apoptosis; Cladribine; DNA Damage; DNA Repair; Drug Synergism; Enzyme Inhibitors; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Vidarabine | 2016 |